Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bobin Chen

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Angewandte Chemie (International Ed. in English)|May 22, 2023
Profiling Phosphoproteome Landscape in Circulating Extracellular Vesicles from Microliters of Biofluids through Functionally Tunable Paramagnetic SeparationJie Sun, Qing Li, Yajie Ding, et al.
Frontiers in Oncology|July 28, 2022
Pemetrexed Plus Lenalidomide for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Prospective Single-Arm Phase II StudyJingjing Ma, Zhiguang Lin, Tianling Ding, et al.
Plos One|November 7, 2015
Synergistic Effect and Molecular Mechanism of Homoharringtonine and Bortezomib on SKM-1 Cell ApoptosisJing Zhang, Bobin Chen, Ting Wu, et al.
Cancer Management and Research|March 14, 2022
Optical Coherence Tomography Benefits the Diagnosis and Follow-Up of Primary Central Nervous System Lymphoma with Intraocular InvolvementXianjin Zhou, Sha Tian, Xian Zhou, et al.
Frontiers in Immunology|February 16, 2026
Exosomal ANGPTL2 in cerebrospinal fluid as a novel prognostic biomarker for primary central nervous system lymphomaLili Zhu, Qing Li, Jingjing Ma, et al.
Neuro-Oncology Advances|March 7, 2023
Cerebrospinal fluid metabolic markers predict prognosis behavior of primary central nervous system lymphoma with high-dose methotrexate-based chemotherapeutic treatmentLiying Zhou, Qing Li, Jingshen Xu, et al.
Annals of Translational Medicine|July 4, 2020
Resveratrol activates DNA damage response through inhibition of polo-like kinase 1 (PLK1) in natural killer/T cell lymphomaXianxian Sui, Canjing Zhang, Yudong Jiang, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 28, 2017
Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathwayXianxian Sui, Canjing Zhang, Jianan Zhou, et al.
The Analyst|July 5, 2023
Phosphoproteome analysis of cerebrospinal fluid extracellular vesicles in primary central nervous system lymphomaYuanyuan Deng, Qing Li, Jie Sun, et al.
Renal Failure|June 15, 2010
Mannitol is an independent risk factor of acute kidney injury after cerebral trauma: a case-control studyLv Fang, Huaizhou You, Bobin Chen, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Angewandte Chemie (International Ed. in English)|May 22, 2023
Profiling Phosphoproteome Landscape in Circulating Extracellular Vesicles from Microliters of Biofluids through Functionally Tunable Paramagnetic SeparationJie Sun, Qing Li, Yajie Ding, et al.
Frontiers in Oncology|July 28, 2022
Pemetrexed Plus Lenalidomide for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Prospective Single-Arm Phase II StudyJingjing Ma, Zhiguang Lin, Tianling Ding, et al.
Plos One|November 7, 2015
Synergistic Effect and Molecular Mechanism of Homoharringtonine and Bortezomib on SKM-1 Cell ApoptosisJing Zhang, Bobin Chen, Ting Wu, et al.
Cancer Management and Research|March 14, 2022
Optical Coherence Tomography Benefits the Diagnosis and Follow-Up of Primary Central Nervous System Lymphoma with Intraocular InvolvementXianjin Zhou, Sha Tian, Xian Zhou, et al.
Frontiers in Immunology|February 16, 2026
Exosomal ANGPTL2 in cerebrospinal fluid as a novel prognostic biomarker for primary central nervous system lymphomaLili Zhu, Qing Li, Jingjing Ma, et al.
Neuro-Oncology Advances|March 7, 2023
Cerebrospinal fluid metabolic markers predict prognosis behavior of primary central nervous system lymphoma with high-dose methotrexate-based chemotherapeutic treatmentLiying Zhou, Qing Li, Jingshen Xu, et al.
Annals of Translational Medicine|July 4, 2020
Resveratrol activates DNA damage response through inhibition of polo-like kinase 1 (PLK1) in natural killer/T cell lymphomaXianxian Sui, Canjing Zhang, Yudong Jiang, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 28, 2017
Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathwayXianxian Sui, Canjing Zhang, Jianan Zhou, et al.
The Analyst|July 5, 2023
Phosphoproteome analysis of cerebrospinal fluid extracellular vesicles in primary central nervous system lymphomaYuanyuan Deng, Qing Li, Jie Sun, et al.
Renal Failure|June 15, 2010
Mannitol is an independent risk factor of acute kidney injury after cerebral trauma: a case-control studyLv Fang, Huaizhou You, Bobin Chen, et al.
Pageof 7